1. Home
  2. BCYC vs XRX Comparison

BCYC vs XRX Comparison

Compare BCYC & XRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • XRX
  • Stock Information
  • Founded
  • BCYC 2009
  • XRX 1906
  • Country
  • BCYC United Kingdom
  • XRX United States
  • Employees
  • BCYC N/A
  • XRX N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • XRX Computer peripheral equipment
  • Sector
  • BCYC Health Care
  • XRX Technology
  • Exchange
  • BCYC Nasdaq
  • XRX Nasdaq
  • Market Cap
  • BCYC 511.4M
  • XRX 474.2M
  • IPO Year
  • BCYC 2019
  • XRX N/A
  • Fundamental
  • Price
  • BCYC $7.39
  • XRX $3.95
  • Analyst Decision
  • BCYC Buy
  • XRX Sell
  • Analyst Count
  • BCYC 8
  • XRX 4
  • Target Price
  • BCYC $29.14
  • XRX $9.50
  • AVG Volume (30 Days)
  • BCYC 438.9K
  • XRX 6.5M
  • Earning Date
  • BCYC 05-01-2025
  • XRX 04-29-2025
  • Dividend Yield
  • BCYC N/A
  • XRX 22.15%
  • EPS Growth
  • BCYC N/A
  • XRX N/A
  • EPS
  • BCYC N/A
  • XRX N/A
  • Revenue
  • BCYC $35,275,000.00
  • XRX $6,221,000,000.00
  • Revenue This Year
  • BCYC N/A
  • XRX $2.01
  • Revenue Next Year
  • BCYC $0.27
  • XRX $14.09
  • P/E Ratio
  • BCYC N/A
  • XRX N/A
  • Revenue Growth
  • BCYC 30.76
  • XRX N/A
  • 52 Week Low
  • BCYC $6.10
  • XRX $3.45
  • 52 Week High
  • BCYC $28.67
  • XRX $16.77
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 40.27
  • XRX 32.54
  • Support Level
  • BCYC $6.10
  • XRX $3.68
  • Resistance Level
  • BCYC $8.00
  • XRX $4.17
  • Average True Range (ATR)
  • BCYC 0.61
  • XRX 0.39
  • MACD
  • BCYC 0.14
  • XRX 0.03
  • Stochastic Oscillator
  • BCYC 46.07
  • XRX 32.47

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About XRX Xerox Holdings Corporation

Xerox Holdings Corp is an original equipment manufacturing and software company. Xerox operates in one segment--design, development, and sale of printing technology and related solutions--while deriving 60% of its revenue from the U.S. and 40% from international markets. The company is an OEM of multifunction printers, or MFPs (printers that can print, copy, and scan), focusing on large enterprise markets. Apart from equipment, the company provides post-sales services like managed print services help to bring smart servicing and efficiencies to how employers use their print/copy equipment. Xerox is attempting to enter new markets like digital print packaging solutions and printed electronics.

Share on Social Networks: